Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Spinal cord quantitative MRI discriminates between disability levels in multiple sclerosis.
Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.
Vitamin D receptor binding, chromatin states and association with multiple sclerosis.
Modeling probability of additional cases of natalizumab-associated JCV sero-negative progressive multifocal leukoencephalopathy.
Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC).
Brain Hemodynamic Changes Associated with Chronic Cerebrospinal Venous Insufficiency Are Not Specific to Multiple Sclerosis and Do Not Increase Its Severity.
Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis.
American Society for Cell Biology Annual Meeting
Mitochondrial approaches for neuroprotection.
Food and Drug Administration Approval Letter for Alemtuzumab
The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community.
Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose.
Substance Name: Amiloride
The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis.
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis.
Microglia activation is associated with IFN-α induced depressive-like behavior.
FTY720 in patients with primary progressive multiple sclerosis (INFORMS)
Physical activity and associated levels of disability and quality of life in people with multiple sclerosis: a large international survey.
Molecular properties of epithelial, amiloride-blockable Na+ channels.
Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies.
A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) (LIBRETTO)
Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.
Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes.
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.

Pages